A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Orciprenaline
Fenoterol
The therapeutic efficacy of Fenoterol can be decreased when used in combination with Tubocurarine.
Orciprenaline
Pentolinium
The therapeutic efficacy of Pentolinium can be decreased when used in combination with Tubocurarine.
Orciprenaline
Epitizide
The serum concentration of Epitizide can be increased when it is combined with Tubocurarine.
Orciprenaline
Cyclopenthiazide
The serum concentration of Cyclopenthiazide can be increased when it is combined with Tubocurarine.
Orciprenaline
Quinethazone
The serum concentration of Quinethazone can be increased when it is combined with Tubocurarine.
Orciprenaline
Polythiazide
The serum concentration of Polythiazide can be increased when it is combined with Tubocurarine.
Orciprenaline
Trichlormethiazide
The serum concentration of Trichlormethiazide can be increased when it is combined with Tubocurarine.
Orciprenaline
Homatropine
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Homatropine.
Orciprenaline
Cyclopentolate
The risk or severity of adverse effects can be increased when Cyclopentolate is combined with Tubocurarine.
Orciprenaline
Peruvoside
The risk or severity of Cardiac Arrhythmia can be increased when Tubocurarine is combined with Peruvoside.
Orciprenaline
Acetyldigoxin
The risk or severity of Cardiac Arrhythmia can be increased when Tubocurarine is combined with Acetyldigoxin.
Orciprenaline
Gitoformate
The risk or severity of Cardiac Arrhythmia can be increased when Tubocurarine is combined with Gitoformate.
Orciprenaline
Lanatoside C
The risk or severity of Cardiac Arrhythmia can be increased when Tubocurarine is combined with Lanatoside C.
Orciprenaline
Metildigoxin
The risk or severity of Cardiac Arrhythmia can be increased when Tubocurarine is combined with Metildigoxin.
Orciprenaline
Proscillaridin
The risk or severity of Cardiac Arrhythmia can be increased when Tubocurarine is combined with Proscillaridin.
Orciprenaline
Cymarin
The risk or severity of Cardiac Arrhythmia can be increased when Tubocurarine is combined with Cymarin.
Orciprenaline
Oleandrin
The risk or severity of Cardiac Arrhythmia can be increased when Tubocurarine is combined with Oleandrin.
Orciprenaline
Digitoxin
The risk or severity of Cardiac Arrhythmia can be increased when Tubocurarine is combined with Digitoxin.
Orciprenaline
Deslanoside
The risk or severity of Cardiac Arrhythmia can be increased when Tubocurarine is combined with Deslanoside.
Orciprenaline
Benzhydrocodone
The risk or severity of adverse effects can be increased when Tubocurarine is combined with Benzhydrocodone.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3